PAVE (Parallactic Visual-Field Enhancement) System for Treatment of Chronic Visual Field Loss Due to Stroke, Traumatic Brain Injury, or Brain Surgery

NAEnrolling by invitationINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 22, 2025

Primary Completion Date

April 5, 2026

Study Completion Date

May 31, 2026

Conditions
Homonymous HemianopsiaHomonymous Quadrantanopia
Interventions
DEVICE

PAVE (Parallactic Visual-Field Enhancement) treatment using a virtual reality head mounted display

PAVE (Parallactic Visual-Field Enhancement) treatment is visual stimulation using a virtual reality head mounted display. The treatment is weekly and entails two 7 minute session separated by a minimum 1 minute intermission. The actual therapy is preceded by a visual field assessment and is followed by a second visual field assessment.

DEVICE

PAVE Placebo

The placebo uses the same PAVE software but the functional aspect of the software that is intended to produce the effect in the test group is absent.

Trial Locations (1)

52404

Dr. D. M. Fitzgerald & Associates, Cedar Rapids

All Listed Sponsors
lead

NeuroAEye LLC

INDUSTRY